 "Eris Lifesciences to make bourse debut on June 29")
New Delhi: Eris Lifesciences is set to debut on the stock market on Thursday after concluding its initial public offer (IPO) last week.
The company’s IPO was subscribed 3.29 times during 16-20 June. The portion set aside for qualified institutional buyers (QIBs) was oversubscribed 4.68 times, non institutional investors 45 percent and retail investors 3.51 times.
Advertisement
The price band for the share sale was fixed at Rs600- 603. The book running lead managers to the offer were Axis Capital, Citigroup Global Markets India and Credit Suisse Securities (India).
Eris Lifesciences is into manufacturing of branded pharmaceutical products in select therapeutic areas
 "Centre allows direct listing of securities by Indian companies on international exchanges of GIFT IFSC")
 "How a busy election year in 2024 could affect global markets")
 "Sensex tanks 931 points, investors lose Rs 9.1 lakh crore")
 "BJP election win cheers Indian stock market; Sensex, Nifty 50 rally to record highs")
 "Centre allows direct listing of securities by Indian companies on international exchanges of GIFT IFSC")
 "How a busy election year in 2024 could affect global markets")
 "Sensex tanks 931 points, investors lose Rs 9.1 lakh crore")
 "BJP election win cheers Indian stock market; Sensex, Nifty 50 rally to record highs")